Short, Strong Signals

Methylation increases both the activity and instability of the signaling protein Notch.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Notch1WIKIMEDIA, HANNES ROSTCellular signals transmitted via the protein Notch are critical for an array of developmental processes in animals. But, if poorly regulated, these signals can contribute to pathologies such as cancer. A report published in Science Signaling yesterday (March 24) reveals that part of the mechanism regulating Notch is the addition of methyl groups that boost the protein’s activity—and hasten its demise.

“While other post-translational modifications have been found in the Notch intracellular domain before, this is a new type of modification, and the biological effects are intriguing,” geneticist Urban Lendahl of the Karolinska Institute in Sweden, who was not involved in the work, wrote in an e-mail to The Scientist.

“[The modification] both leads to the degradation of Notch, but it is also very important for activation. It has an enigmatic role,” agreed geneticist Rhett Kovall of the University of Cincinnati, who also did not participate in the study.

Notch proteins are a family of transmembrane receptors conserved across the animal kingdom that are essential for normal embryonic and postnatal development. Notch is also essential for ongoing differentiation processes in adults, such as the continuous formation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies